Tara Man Kadayat

993 citations

41 papers · 854 indexed · h-index 20

Co-authors: Youngjoo Kwon Eung-Seok Lee Aarajana Shrestha Ganesh Bist Til Bahadur Thapa Magar Radha Karki Younghwa Na Chanmi Park
Topics: Cancer therapeutics and mechanisms (26 papers)Bioactive Compounds and Antitumor Agents (23 papers)Synthesis and biological activity (17 papers)
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: Chemical Communications Journal of Medicinal Chemistry European Journal of Pharmacology
Partner nations: South Korea United States Switzerland

In The Last Decade

Tara Man Kadayat

41 papers receiving 849 citations

Peers

Countries citing papers authored by Tara Man Kadayat

Since Specialization

Citations

This map shows the geographic impact of Tara Man Kadayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Man Kadayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Man Kadayat more than expected).

Fields of papers citing papers by Tara Man Kadayat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Man Kadayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Man Kadayat. The network helps show where Tara Man Kadayat may publish in the future.

Co-authorship network of co-authors of Tara Man Kadayat

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Man Kadayat. A scholar is included among the top collaborators of Tara Man Kadayat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Man Kadayat. Tara Man Kadayat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Soo‐Yeon Hwang,(unknown),Tara Man Kadayat,(unknown),Youngjoo Kwon,Eung-Seok Lee	3
2	Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison 2021 ·European Journal of Medicinal Chemistry ·(unknown),Soo‐Yeon Hwang,(unknown),Seojeong Park,(unknown),Daeun Kim,Tara Man Kadayat,Youngjoo Kwon,Eung-Seok Lee	8
3	Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives 2021 ·Journal of Medicinal Chemistry ·Aarajana Shrestha,(unknown),Su‐Jeong Lee,Yong Hyun Jeon,Ji‐Joon Song,Hongchan An,Sung Jin Cho,Tara Man Kadayat,Jungwook Chin	23
4	Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors 2021 ·European Journal of Medicinal Chemistry ·Soo‐Yeon Hwang,Aarajana Shrestha,Seojeong Park,Ganesh Bist,(unknown),Tara Man Kadayat,(unknown),Minjung Seo,(unknown),(unknown),(unknown),Eung-Seok Lee,Youngjoo Kwon	10
5	Ameliorating effect of TI-1-162, a hydroxyindenone derivative, against TNBS-induced rat colitis is mediated through suppression of RIP/ASK-1/MAPK signaling 2018 ·European Journal of Pharmacology ·(unknown),Suhrid Banskota,Nikita Katila,Jaya Gautam,Tara Man Kadayat,Dong‐Young Choi,Eung Seok Lee,Tae Cheon Jeong,Jung‐Ae Kim	9
6	Synthesis and evaluation of an orally available “Y”-shaped biaryl peroxisome proliferator-activated receptor δ agonist 2018 ·Bioorganic & Medicinal Chemistry ·Dong‐Su Kim,John J. Lee,Ashwini M. Londhe,Tara Man Kadayat,(unknown),Hayoung Hwang,Kyung‐Hee Kim,Ae Nim Pae,Jungwook Chin,Sung Jin Cho,Heonjoong Kang	5
7	Design, synthesis, biological evaluation, structure-activity relationship study, and mode of action of 2-phenol-4,6-dichlorophenyl-pyridines 2018 ·Bioorganic Chemistry ·Aarajana Shrestha,Seojeong Park,(unknown),Tara Man Kadayat,Ganesh Bist,(unknown),Youngjoo Kwon,Eung-Seok Lee	18
8	Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase IIα-targeting anticancer agents 2018 ·Bioorganic & Medicinal Chemistry ·Til Bahadur Thapa Magar,(unknown),Tara Man Kadayat,Hyunji Jo,Aarajana Shrestha,Ganesh Bist,(unknown),Youngjoo Kwon,Eung-Seok Lee	19
9	Synthesis and biological evaluation of pyridine-linked indanone derivatives: Potential agents for inflammatory bowel disease 2018 ·Bioorganic & Medicinal Chemistry Letters ·Tara Man Kadayat,Suhrid Banskota,Ganesh Bist,(unknown),Til Bahadur Thapa Magar,Aarajana Shrestha,Jung‐Ae Kim,Eung-Seok Lee	14
10	Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-Activated Receptor δ Agonist 2018 ·ACS Omega ·(unknown),(unknown),(unknown),Dongyup Hahn,Dayoung Kim,Tara Man Kadayat,Kyungjin Jung,Jina Kim,Dong‐Su Kim,(unknown),(unknown),Kyung‐Hee Kim,Sang‐Jip Nam,Sung Jin Cho,Jungwook Chin	5
11	2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent 2017 ·Bioorganic & Medicinal Chemistry Letters ·Til Bahadur Thapa Magar,Tara Man Kadayat,(unknown),Seojeong Park,Ganesh Bist,Aarajana Shrestha,Youngjoo Kwon,Eung-Seok Lee	20
12	A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study 2016 ·European Journal of Medicinal Chemistry ·Radha Karki,Kyu-Yeon Jun,Tara Man Kadayat,(unknown),Til Bahadur Thapa Magar,Ganesh Bist,Aarajana Shrestha,Younghwa Na,Youngjoo Kwon,Eung-Seok Lee	22
13	Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents 2016 ·Bioorganic Chemistry ·(unknown),Tara Man Kadayat,Seojeong Park,(unknown),Til Bahadur Thapa Magar,Ganesh Bist,Aarajana Shrestha,Younghwa Na,Youngjoo Kwon,Eung-Seok Lee	13
14	Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines 2016 ·Bioorganic & Medicinal Chemistry Letters ·Tara Man Kadayat,Seojeong Park,Kyu-Yeon Jun,Til Bahadur Thapa Magar,Ganesh Bist,Aarajana Shrestha,Younghwa Na,Youngjoo Kwon,Eung-Seok Lee	19
15	Novel 2-aryl-4-(4′-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors 2016 ·European Journal of Medicinal Chemistry ·Seojeong Park,Tara Man Kadayat,(unknown),Til Bahadur Thapa Magar,Ganesh Bist,Aarajana Shrestha,Eung-Seok Lee,Youngjoo Kwon	24
16	Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines 2015 ·Bioorganic & Medicinal Chemistry ·Tara Man Kadayat,(unknown),(unknown),Til Bahadur Thapa Magar,Ganesh Bist,Aarajana Shrestha,(unknown),Younghwa Na,Youngjoo Kwon,Eung-Seok Lee	25
17	Topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines 2015 ·Bioorganic & Medicinal Chemistry ·Radha Karki,(unknown),Tara Man Kadayat,Til Bahadur Thapa Magar,Ganesh Bist,Aarajana Shrestha,Younghwa Na,Youngjoo Kwon,Eung-Seok Lee	39
18	Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase IIα catalytic inhibitor 2014 ·European Journal of Medicinal Chemistry ·Tara Man Kadayat,Chanmi Park,Kyu-Yeon Jun,Til Bahadur Thapa Magar,Ganesh Bist,(unknown),Youngjoo Kwon,Eung-Seok Lee	32
19	Synthesis, antitumor activity, and structure–activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors 2014 ·European Journal of Medicinal Chemistry ·Radha Karki,Chanmi Park,Kyu-Yeon Jun,Jun-Goo Jee,(unknown),(unknown),Tara Man Kadayat,Youngjoo Kwon,Eung-Seok Lee	33
20	Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety 2012 ·European Journal of Medicinal Chemistry ·(unknown),Radha Karki,(unknown),Tara Man Kadayat,Eun‐Young Lee,(unknown),Younghwa Na,Won-Jea Cho,Nam Doo Kim,Byeong-Seon Jeong,Youngjoo Kwon,Eung-Seok Lee	58

About Tara Man Kadayat

Tara Man Kadayat is a scholar working on Toxicology, Organic Chemistry and Molecular Biology, having authored 41 papers that have together received 854 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (26 papers), Bioactive Compounds and Antitumor Agents (23 papers) and Synthesis and biological activity (17 papers). The work is most often cited by research in Toxicology (201 citations), Organic Chemistry (522 citations) and Molecular Biology (476 citations). Tara Man Kadayat has collaborated with scholars based in South Korea, United States and Switzerland. Frequent co-authors include Youngjoo Kwon, Eung-Seok Lee, Aarajana Shrestha, Ganesh Bist, Til Bahadur Thapa Magar, Radha Karki, Younghwa Na, Eung-Seok Lee, Chanmi Park and Kyu-Yeon Jun. Their work appears in journals such as Chemical Communications, Journal of Medicinal Chemistry and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact